Inhibition of citrus flavonoids on 12-O-tetradecanoylphorbol 13-acetate-induced skin inflammation and tumorigenesis in mice

Food Science and Human Wellness

Volumn 1, Issue 1, 2012, Pages 65-73

  Pan, Min Hsiung ^a   Li, Shiming ^b   Lai, Ching Shu ^a   Miyauchi, Yutaka ^c   Suzawa, Michiko ^c   Ho, Chi Tang ^b  

^a NATIONAL KAOHSIUNG UNIVERSITY OF APPLIED SCIENCES   (Taiwan)

^b RUTGERS UNIVERSITY   (United States)

^c Miyauchi Citrus Research Center   (Japan)

Author keywords

Citrus flavonoids; Inflammation; Inhibition; Skin cancer; Tumorigenesis

Indexed keywords

EID: 85068980784     PISSN: None     EISSN: 22134530     Source Type: Journal    
DOI: 10.1016/j.fshw.2012.09.001     Document Type: Article

References (31)

1. Pan, M.H., Chen, W.J., Lin-Shiau, S.Y., Ho, C.T., Lin, J.K., Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells. Carcinogenesis 23:10 (2002), 1677–1684.
2. Manthey, J.A., Grohmann, K., Guthrie, N., Biological properties of citrus flavonoids pertaining to cancer and inflammation. Current Medicinal Chemistry 8:2 (2001), 135–153.
3. Yoshimizu, N., Otani, Y., Saikawa, Y., Kubota, T., et al. Anti-tumour effects of nobiletin, a citrus flavonoid, on gastric cancer include: antiproliferative effects, induction of apoptosis and cell cycle deregulation. Alimentary Pharmacology and Therapeutics 20:Suppl. 1 (2004), 95–101.
4. Bas, E., Recio, M.C., Giner, R.M., Manez, S., et al. Anti-inflammatory activity of 5-O-demethylnobiletin, a polymethoxyflavone isolated from Sideritis tragoriganum. Planta Medica 72:2 (2006), 136–142.
5. Wattenberg, L.W., Chemoprevention of cancer. Cancer Research 45:1 (1985), 1–8.
6. Murakami, A., Nakamura, Y., Torikai, K., Tanaka, T., et al. Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice. Cancer Research 60:18 (2000), 5059–5066.
7. Balkwill, F., Coussens, L.M., Cancer: an inflammatory link. Nature 431:7007 (2004), 405–406.
8. Wu, X., Pandolfi, P.P., Mouse models for multistep tumorigenesis. Trends in Cell Biology 11:11 (2001), S2–S9.
9. Raick, A.N., Late ultrastructural changes induced by 12-O-tetradecanoyl-phorbol-13-acetate in mouse epidermis and their reversal. Cancer Research 33:5 (1973), 1096–1103.
10. Raick, A.N., Ultrastructural, histological, and biochemical alterations produced by 12-O-tetradecanoyl-phorbol-13-acetate on mouse epidermis and their relevance to skin tumor promotion. Cancer Research 33:2 (1973), 269–286.
11. Seo, H.J., Park, K.K., Han, S.S., Chung, W.Y., et al. Inhibitory effects of the standardized extract (DA-9601) of Artemisia asiatica Nakai on phorbol ester-induced ornithine decarboxylase activity, papilloma formation, cyclooxygenase-2 expression, inducible nitric oxide synthase expression and nuclear transcription factor kappa B activation in mouse skin. International Journal of Cancer 100:4 (2002), 456–462.
12. Ohshima, H., Tazawa, H., Sylla, B.S., Sawa, T., Prevention of human cancer by modulation of chronic inflammatory processes. Mutation Research 591:1–2 (2005), 110–122.
13. DiGiovanni, J., Multistage carcinogenesis in mouse skin. Pharmacology & Therapeutics 54:1 (1992), 63–128.
14. Yuspa, S.H., The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis – thirty-third G.H.A. Clowes Memorial Award Lecture. Cancer Research 54:5 (1994), 1178–1189.
15. Slaga, T.J., Fischer, S.M., Weeks, C.E., Klein-Szanto, A.J., Reiners, J., Studies on the mechanisms involved in multistage carcinogenesis in mouse skin. Journal of Cellular Biochemistry 18:1 (1982), 99–119.
16. Slaga, T.J., Overview of tumor promotion in animals. Environmental Health Perspectives 50 (1983), 3–14.
17. Lai, C.S., Li, S., Chai, C.Y., Lo, C.Y., et al. Anti-inflammatory and antitumor promotional effects of a novel urinary metabolite, 3′,4′-didemethylnobiletin, derived from nobiletin. Carcinogenesis 29:12 (2008), 2415–2424.
18. Lai, C.S., Li, S., Chai, C.Y., Lo, C.Y., et al. Inhibitory effect of citrus 5-hydroxy-3,6,7,8,3′,4′-hexamethoxyflavone on 12-O-tetradecanoylphorbol 13-acetate-induced skin inflammation and tumor promotion in mice. Carcinogenesis 28:12 (2007), 2581–2588.
19. Wood, L.C., Jackson, S.M., Elias, P.M., Grunfeld, C., Feingold, K.R., Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. Journal of Clinical Investigation 90:2 (1992), 482–487.
20. Pegg, A.E., Regulation of ornithine decarboxylase. Journal of Biological Chemistry 281:21 (2006), 14529–14532.
21. O‘Brien, T.G., Simsiman, R.C., Boutwell, R.K., Induction of the polyamine-biosynthetic enzymes in mouse epidermis by tumor-promoting agents. Cancer Research 35:7 (1975), 1662–1670.
22. Hennings, H., Glick, A.B., Greenhalgh, D.A., Morgan, D.L., et al. Critical aspects of initiation, promotion, and progression in multistage epidermal carcinogenesis. Proceedings of the Society for Experimental Biology and Medicine 202:1 (1993), 1–8.
23. Slaga, T.J., DiGiovanni, J., Winberg, L.D., Budunova, I.V., Skin carcinogenesis: characteristics, mechanisms, and prevention. Progress in Clinical and Biological Research 391 (1995), 1–20.
24. Chun, K.S., Surh, Y.J., Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention. Biochemical Pharmacology 68:6 (2004), 1089–1100.
25. Kleinert, H., Schwarz, P.M., Forstermann, U., Regulation of the expression of inducible nitric oxide synthase. Biological Chemistry 384:10–11 (2003), 1343–1364.
26. Ho, Y.S., Lai, C.S., Liu, H.I., Ho, S.Y., et al. Dihydrolipoic acid inhibits skin tumor promotion through anti-inflammation and anti-oxidation. Biochemical Pharmacology 73:11 (2007), 1786–1795.
27. O‘Brien, T.G., The induction of ornithine decarboxylase as an early, possibly obligatory, event in mouse skin carcinogenesis. Cancer Research 36:7 PT 2 (1976), 2644–2653.
28. Raick, A.N., Thumm, K., Chivers, B.R., Early effects of 12-O-tetradecanoyl-phorbol-13-acetate on the incorporation of tritiated precursor into DNA and the thickness of the interfollicular epidermis, and their relation to tumor promotion in mouse skin. Cancer Research 32:7 (1972), 1562–1568.
29. Alford, J.G., Stanley, P.L., Todderud, G., Tramposch, K.M., Temporal infiltration of leukocyte subsets into mouse skin inflamed with phorbol ester. Agents and Actions 37:3–4 (1992), 260–267.
30. Larcher, F., Robles, A.I., Duran, H., Murillas, R., et al. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels. Cancer Research 56:23 (1996), 5391–5396.
31. Gately, S., Li, W.W., Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy. Seminars in Oncology 31:2 Suppl. 7 (2004), 2–11.